Skip to main content
Top

2021 | OriginalPaper | Hoofdstuk

3. Preexistent chronic disorders, often directly affecting pregnancy

Auteurs : Dr. L. L. H. Peeters, Prof. Dr. P. W. de Leeuw, Dr. E. D. Post Uiterweer

Gepubliceerd in: Pathophysiology of pregnancy complications

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

The first two chapters describe the strategy in mammalian pregnancy in general and human pregnancy in particular, how to secure the survival of the species without compromising maternal health. The first chapter discusses the specific adaptive strategy that a pregnant woman utilizes to achieve this goal. She temporarily accommodates an immunologically different human being within her body and by supplying this new life with sufficient O2, nutrients and disposing of its metabolic waste products, enables it to grow and mature, in line with its genetic potential. She does this in a setting, that allows her to shield the infant from external stress factors, such as excessive heat, – cold and – physical forces and, last but not least, she provides the infant with the means to safely exit the maternal body to the outer world at a suitable time. Yet, even seemingly-healthy women may develop common pregnancy complications, such as early pregnancy loss, placental syndromes, preterm birth and gestational diabetes. These complications are often superimposed on a preexistent, often latent defect in the maternal cardiovascular system (sect. 3.1), renal function (sect. 3.2), metabolism (sect. 3.3), certain liver functions (sect. 3.4), or the immune – (sect. 3.5) and clotting systems (sect. 3.6). Such a defect limits a woman’s capacity to adapt to pregnancy and therefore, predisposes her to one of these pregnancy complications. This chapter describes the course and outcome of pregnancy in women with a chronic disorder affecting one of these six maternal functions and also, whether pregnancy will alter the course of her underlying chronic disorder.
Literatuur
go back to reference Acharya A. Management of acute kidney injury in pregnancy for the obstetrician. Obstet Gynecol Clin N Am. 2016;43:747–65. Acharya A. Management of acute kidney injury in pregnancy for the obstetrician. Obstet Gynecol Clin N Am. 2016;43:747–65.
go back to reference Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24:252–9.PubMedCrossRef Alkhunaizi A, Melamed N, Hladunewich MA. Pregnancy in advanced chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2015;24:252–9.PubMedCrossRef
go back to reference Anders H, Rovin B. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int. 2016;90:493–501.PubMedCrossRef Anders H, Rovin B. A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis. Kidney Int. 2016;90:493–501.PubMedCrossRef
go back to reference Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders. Autoimmune Rev. 2015;14:174–80.CrossRef Antonelli A, Ferrari SM, Corrado A, et al. Autoimmune thyroid disorders. Autoimmune Rev. 2015;14:174–80.CrossRef
go back to reference Arachchillage DRJ, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017;178:181–6.PubMedCrossRef Arachchillage DRJ, Laffan M. Pathogenesis and management of antiphospholipid syndrome. Br J Haematol. 2017;178:181–6.PubMedCrossRef
go back to reference Arya R. Pregnancy outcome in women with mechanical prosthetic heart valves. Thromb Res. 2019;181(Suppl. 1):S37–40.PubMedCrossRef Arya R. Pregnancy outcome in women with mechanical prosthetic heart valves. Thromb Res. 2019;181(Suppl. 1):S37–40.PubMedCrossRef
go back to reference Atalla RK, Thompson JR, Oppenheimer CA, et al. Reactive thrombocytosis after caesarean section and vaginal delivery: implications for maternal thromboembolism and its prevention. Brit J Obstet Gynaecol. 2000;107:411–4.CrossRef Atalla RK, Thompson JR, Oppenheimer CA, et al. Reactive thrombocytosis after caesarean section and vaginal delivery: implications for maternal thromboembolism and its prevention. Brit J Obstet Gynaecol. 2000;107:411–4.CrossRef
go back to reference Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy – review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Med. 2000;93:157–65.CrossRef Aubard Y, Darodes N, Cantaloube M. Hyperhomocysteinemia and pregnancy – review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Med. 2000;93:157–65.CrossRef
go back to reference Audia S, Godeau B, Bonnotte B. Is there still a place for “old therapies” in the management of immune thrombocytopenia? Rev Med Interne. 2016;37:43–9.PubMedCrossRef Audia S, Godeau B, Bonnotte B. Is there still a place for “old therapies” in the management of immune thrombocytopenia? Rev Med Interne. 2016;37:43–9.PubMedCrossRef
go back to reference Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16:620–32.PubMedCrossRef Audia S, Mahévas M, Samson M, Godeau B, Bonnotte B. Pathogenesis of immune thrombocytopenia. Autoimmun Rev. 2017;16:620–32.PubMedCrossRef
go back to reference Balsells M, Garcia-Patterson A, Gich I, Corcay R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2009;94:4284–91.PubMedCrossRef Balsells M, Garcia-Patterson A, Gich I, Corcay R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2009;94:4284–91.PubMedCrossRef
go back to reference Banerjee D, Ventetuolo CE. Pulmonary hypertension in Pregnancy. Semin Respir Crit Care Med. 2017;38:148–59.PubMedCrossRef Banerjee D, Ventetuolo CE. Pulmonary hypertension in Pregnancy. Semin Respir Crit Care Med. 2017;38:148–59.PubMedCrossRef
go back to reference Belomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–66.CrossRef Belomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380:756–66.CrossRef
go back to reference Bhagra C, D’Souza R, Silversides CK. Valvular heart disease and pregnancy part II: management of prosthetic valves. Heart. 2017;103:244–52.PubMedCrossRef Bhagra C, D’Souza R, Silversides CK. Valvular heart disease and pregnancy part II: management of prosthetic valves. Heart. 2017;103:244–52.PubMedCrossRef
go back to reference Bissonnette J, Durand F, De Raucourt E, Ceccaldo PF, Plessier A, Valla D, Rautou PE. Pregnancy and vascular liver disease. J Clin Exp Hepatol. 2015;5:41–50.PubMedPubMedCentralCrossRef Bissonnette J, Durand F, De Raucourt E, Ceccaldo PF, Plessier A, Valla D, Rautou PE. Pregnancy and vascular liver disease. J Clin Exp Hepatol. 2015;5:41–50.PubMedPubMedCentralCrossRef
go back to reference Bove R, Alwan S, Friedman JM, Hellwig K, et al. Management of multiple sclerosis during pregnancy and the reproductive years. A systematic review. Obstet Gynecol. 2014;124:1157–68.PubMedCrossRef Bove R, Alwan S, Friedman JM, Hellwig K, et al. Management of multiple sclerosis during pregnancy and the reproductive years. A systematic review. Obstet Gynecol. 2014;124:1157–68.PubMedCrossRef
go back to reference Braga AC, Vasconcelos C, Braga J. Pregnancy with autoimmune hepatitis. Gastroenterol Hepatol Bed Bench. 2016;9:220–4.PubMedPubMedCentral Braga AC, Vasconcelos C, Braga J. Pregnancy with autoimmune hepatitis. Gastroenterol Hepatol Bed Bench. 2016;9:220–4.PubMedPubMedCentral
go back to reference Brucato A, Frassi M, Franceschini F, Cimaz R, et al. Risk of congenital complete heart block in newborns of mothers with anti-Rho/SSA antibodies detected by counter-immuno-electrophoresis. A prospective study of 100 women. Arthitis Rheum. 2001;44:1832–5. Brucato A, Frassi M, Franceschini F, Cimaz R, et al. Risk of congenital complete heart block in newborns of mothers with anti-Rho/SSA antibodies detected by counter-immuno-electrophoresis. A prospective study of 100 women. Arthitis Rheum. 2001;44:1832–5.
go back to reference Buyon JP, Hiebert R, Copel J, Craft J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrent rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–66.PubMedCrossRef Buyon JP, Hiebert R, Copel J, Craft J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrent rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998;31:1658–66.PubMedCrossRef
go back to reference Campos O, Andrade JL, Bocanegra J. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol. 1993;40:265–72.PubMedCrossRef Campos O, Andrade JL, Bocanegra J. Physiologic multivalvular regurgitation during pregnancy: a longitudinal Doppler echocardiographic study. Int J Cardiol. 1993;40:265–72.PubMedCrossRef
go back to reference Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of pregnancy in patients with complex congenital heart disease. Circulation. 2017;135:e50–87.PubMedCrossRef Canobbio MM, Warnes CA, Aboulhosn J, et al. Management of pregnancy in patients with complex congenital heart disease. Circulation. 2017;135:e50–87.PubMedCrossRef
go back to reference Castellano JM, Narayan RL, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nature Cardiol. 2012;9:415–24.CrossRef Castellano JM, Narayan RL, Vaishnava P, et al. Anticoagulation during pregnancy in patients with a prosthetic heart valve. Nature Cardiol. 2012;9:415–24.CrossRef
go back to reference Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. Am J Surg. 2012;203:589–93.PubMedCrossRef Causey MW, Steele SR, Farris Z, Lyle DS, Beitler AL. An assessment of different scoring systems in cirrhotic patients undergoing nontransplant surgery. Am J Surg. 2012;203:589–93.PubMedCrossRef
go back to reference Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of Glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 2019;4:1–5. Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M. Consequences of Glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 2019;4:1–5.
go back to reference Chandrakala M, Suthanthira K. Glanzmann’s thrombasthenia complicating pregnancy. J Obstet Gynecol India. 2014;64:S3–5.CrossRef Chandrakala M, Suthanthira K. Glanzmann’s thrombasthenia complicating pregnancy. J Obstet Gynecol India. 2014;64:S3–5.CrossRef
go back to reference Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.PubMedCrossRef Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51:660–78.PubMedCrossRef
go back to reference Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun. 2017;83:31–42.PubMedCrossRef Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun. 2017;83:31–42.PubMedCrossRef
go back to reference Christensen JJ, Retterstol K, Godang K, et al. LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors. J Clin Lipidol. 2016;10:1369–78.PubMedCrossRef Christensen JJ, Retterstol K, Godang K, et al. LDL cholesterol in early pregnancy and offspring cardiovascular disease risk factors. J Clin Lipidol. 2016;10:1369–78.PubMedCrossRef
go back to reference Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med. 2014;43:e49–59.PubMedCrossRef Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med. 2014;43:e49–59.PubMedCrossRef
go back to reference Crousillat DR, Wood MJ. Valvular heart disease and heart failure in women. Heart Failure clin. 2019;15:77–85.CrossRef Crousillat DR, Wood MJ. Valvular heart disease and heart failure in women. Heart Failure clin. 2019;15:77–85.CrossRef
go back to reference Dal-Bianco JP, Beaudoin J, Levine RA. Basic mechanisms of mitral valve regurgitation. Can J Cardiol. 2014;30:971–81.PubMedCrossRef Dal-Bianco JP, Beaudoin J, Levine RA. Basic mechanisms of mitral valve regurgitation. Can J Cardiol. 2014;30:971–81.PubMedCrossRef
go back to reference De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6:575–86.PubMedCrossRef De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6:575–86.PubMedCrossRef
go back to reference De Man YA, Dolhain RJEM, Van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241–8.PubMedCrossRef De Man YA, Dolhain RJEM, Van de Geijn FE, Willemsen SP, Hazes JMW. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241–8.PubMedCrossRef
go back to reference De Santis M, Cavaliere AF, Straface G, et al. Inherited and acquired thrombophilia: pregnancy outcome and treatment. Reprod Toxicol. 2006;22:227–33.PubMedCrossRef De Santis M, Cavaliere AF, Straface G, et al. Inherited and acquired thrombophilia: pregnancy outcome and treatment. Reprod Toxicol. 2006;22:227–33.PubMedCrossRef
go back to reference Dekker RR, Schutte JM, Stekelenburg J, Zwart JJ, Van Roosmalen J. Maternal mortality and severe maternal morbidity from acute fatty liver of pregnancy in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;157:27–31.PubMedCrossRef Dekker RR, Schutte JM, Stekelenburg J, Zwart JJ, Van Roosmalen J. Maternal mortality and severe maternal morbidity from acute fatty liver of pregnancy in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2011;157:27–31.PubMedCrossRef
go back to reference Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–58.PubMedCrossRef Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15:545–58.PubMedCrossRef
go back to reference De Vloo C, Nevens F. Cholestatic pruritus: an update (review). Acta Gastroenterol Belg 2019; 82: 75-82. De Vloo C, Nevens F. Cholestatic pruritus: an update (review). Acta Gastroenterol Belg 2019; 82: 75-82.
go back to reference Dennis AT. Heart failure in pregnant women: is it peripartum cardiomyopathy? (focused review). Anesth Analg. 2015;120:638–43. Dennis AT. Heart failure in pregnant women: is it peripartum cardiomyopathy? (focused review). Anesth Analg. 2015;120:638–43.
go back to reference Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40:141–53.PubMedCrossRef Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40:141–53.PubMedCrossRef
go back to reference Donovan JL, Tran MT, Kanaan AO. An overview of heparin-induced thrombocytopenia. J Pharm Pract. 2010;23:226–34.PubMedCrossRef Donovan JL, Tran MT, Kanaan AO. An overview of heparin-induced thrombocytopenia. J Pharm Pract. 2010;23:226–34.PubMedCrossRef
go back to reference Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391:2547–59.PubMedCrossRef Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391:2547–59.PubMedCrossRef
go back to reference Eapen DJ, Valiani K, Reddy S, Sperling L. Management of familial hypercholesterolemia during pregnancy: case series and discussion. J Clin Lipidol. 2012;6:88–91.PubMedCrossRef Eapen DJ, Valiani K, Reddy S, Sperling L. Management of familial hypercholesterolemia during pregnancy: case series and discussion. J Clin Lipidol. 2012;6:88–91.PubMedCrossRef
go back to reference Effraimidis G, Wiersinga WM. Autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170:R241–52.PubMedCrossRef Effraimidis G, Wiersinga WM. Autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170:R241–52.PubMedCrossRef
go back to reference Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public health challenge. Lancet. 2006;367:1352–61.PubMedCrossRef Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public health challenge. Lancet. 2006;367:1352–61.PubMedCrossRef
go back to reference Elliott MA. Thrombocythaemia and pregnancy. Best Pract Res Clin Hematol. 2003;16:227–42.CrossRef Elliott MA. Thrombocythaemia and pregnancy. Best Pract Res Clin Hematol. 2003;16:227–42.CrossRef
go back to reference Emmanuel Y, Thorne SA. Heart disease in pregnancy. Best Pract Res Clin Obstet Gynecol. 2015;29:579–97.CrossRef Emmanuel Y, Thorne SA. Heart disease in pregnancy. Best Pract Res Clin Obstet Gynecol. 2015;29:579–97.CrossRef
go back to reference Fakhouri F, Roumenina L, Provot F, Sallée M, et al. Pregnancy-associated hemolytic-uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010;21:859–67.PubMedPubMedCentralCrossRef Fakhouri F, Roumenina L, Provot F, Sallée M, et al. Pregnancy-associated hemolytic-uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol. 2010;21:859–67.PubMedPubMedCentralCrossRef
go back to reference Fakhouri F. Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus Apher Sci. 2016;54:199–202.PubMedCrossRef Fakhouri F. Pregnancy-related thrombotic microangiopathies: clues from complement biology. Transfus Apher Sci. 2016;54:199–202.PubMedCrossRef
go back to reference Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14:132–45.PubMedCrossRef Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14:132–45.PubMedCrossRef
go back to reference Floreani A, Restrepo-Jimémenez P, Secchi MF, et al. Etiopathogenesis of autoimmune hepatitis. J Autoimmun. 2018;95:133–43.PubMedCrossRef Floreani A, Restrepo-Jimémenez P, Secchi MF, et al. Etiopathogenesis of autoimmune hepatitis. J Autoimmun. 2018;95:133–43.PubMedCrossRef
go back to reference Fogerty AE. Thrombocytopenia in pregnancy: mechanisms and management. Transfus Med Rev. 2018;32:225–9.PubMedCrossRef Fogerty AE. Thrombocytopenia in pregnancy: mechanisms and management. Transfus Med Rev. 2018;32:225–9.PubMedCrossRef
go back to reference Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11:76–87.PubMedCrossRef Fogo AB. Causes and pathogenesis of focal segmental glomerulosclerosis. Nat Rev Nephrol. 2015;11:76–87.PubMedCrossRef
go back to reference Folkeringa N, Brouwer JLP, Korteweg FJ, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007;136:656–61.PubMedCrossRef Folkeringa N, Brouwer JLP, Korteweg FJ, et al. Reduction of high fetal loss rate by anticoagulant treatment during pregnancy in antithrombin, protein C or protein S deficient women. Br J Haematol. 2007;136:656–61.PubMedCrossRef
go back to reference Franchini M, Veneri D, Lippi G. Thrombocytopenia and infections. Review. Expert Rev Hematol. 2017;10:99–106.PubMedCrossRef Franchini M, Veneri D, Lippi G. Thrombocytopenia and infections. Review. Expert Rev Hematol. 2017;10:99–106.PubMedCrossRef
go back to reference Franco V, Ryan JJ, McLaughlin VV. Pulmonary hypertension in women. Heart Failure Clin. 2019;15:137–45.CrossRef Franco V, Ryan JJ, McLaughlin VV. Pulmonary hypertension in women. Heart Failure Clin. 2019;15:137–45.CrossRef
go back to reference Fraser A, Lawlor DA. Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr Diab Rep. 2014;14:489, 8 pages. Fraser A, Lawlor DA. Long-term health outcomes in offspring born to women with diabetes in pregnancy. Curr Diab Rep. 2014;14:489, 8 pages.
go back to reference Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of a typical hemolytic uremic syndrome: a nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013;8:554–62.PubMedPubMedCentralCrossRef Fremeaux-Bacchi V, Fakhouri F, Garnier A, et al. Genetics and outcome of a typical hemolytic uremic syndrome: a nationwide french series comparing children and adults. Clin J Am Soc Nephrol. 2013;8:554–62.PubMedPubMedCentralCrossRef
go back to reference Fujioka K. Pathophysiology of type 2 diabetes and the role of incretin hormones and beta-cell dysfunction. JAAPA. 2007; Suppl 3–8. Fujioka K. Pathophysiology of type 2 diabetes and the role of incretin hormones and beta-cell dysfunction. JAAPA. 2007; Suppl 3–8.
go back to reference Galiè N, Humbert M, Vachiery JL, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67–119.PubMedCrossRef Galiè N, Humbert M, Vachiery JL, et al. ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2016;37:67–119.PubMedCrossRef
go back to reference Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc. 2003;78:447–56.PubMedCrossRef Gerich JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc. 2003;78:447–56.PubMedCrossRef
go back to reference Giard JM, Terrault NA. Women with cirrhosis. Prevalence, natural history, management. Gastroenterol Clin N Am. 2016;45:345–58. Giard JM, Terrault NA. Women with cirrhosis. Prevalence, natural history, management. Gastroenterol Clin N Am. 2016;45:345–58.
go back to reference Gidding SS, Champagne MA, De Ferranti SD, et al. The agenda for familial hypercholesterolemia. A scientific statement from the American heart association. Circulation. 2015;132:2167–92. Gidding SS, Champagne MA, De Ferranti SD, et al. The agenda for familial hypercholesterolemia. A scientific statement from the American heart association. Circulation. 2015;132:2167–92.
go back to reference Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Curr Cardiol Rep. 2017;19:96, 7 pages. Goldstein SA, Ward CC. Congenital and acquired valvular heart disease in pregnancy. Curr Cardiol Rep. 2017;19:96, 7 pages.
go back to reference Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Genes. 2018;668:59–72. Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Genes. 2018;668:59–72.
go back to reference GrØnbæk L, Vilstrup H, Jepsen P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Alim Pharmacol Ther. 2018;48:655–63.CrossRef GrØnbæk L, Vilstrup H, Jepsen P. Pregnancy and birth outcomes in a Danish nationwide cohort of women with autoimmune hepatitis and matched population controls. Alim Pharmacol Ther. 2018;48:655–63.CrossRef
go back to reference Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol. 2015;22:445–51.PubMedPubMedCentralCrossRef Grozovsky R, Giannini S, Falet H, Hoffmeister KM. Novel mechanisms of platelet clearance and thrombopoietin regulation. Curr Opin Hematol. 2015;22:445–51.PubMedPubMedCentralCrossRef
go back to reference Gundlapalli AV, Scalchunes C, Boyle M, et al. Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey. J Clin Immunol. 2015;35:125–34.PubMedPubMedCentralCrossRef Gundlapalli AV, Scalchunes C, Boyle M, et al. Fertility, pregnancies and outcomes reported by females with common variable immune deficiency and hypogammaglobulinemia: results from an internet-based survey. J Clin Immunol. 2015;35:125–34.PubMedPubMedCentralCrossRef
go back to reference HAPO study cooperative research group; Metzger BE, et al. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358:1991–2002. HAPO study cooperative research group; Metzger BE, et al. Hyperglycemia and adverse pregnancy outcomes. New Engl J Med. 2008;358:1991–2002.
go back to reference Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with thrombocytosis. Brit J Haematol. 2010;149:352–75.CrossRef Harrison CN, Bareford D, Butt N, et al. Guideline for investigation and management of adults and children presenting with thrombocytosis. Brit J Haematol. 2010;149:352–75.CrossRef
go back to reference Hazes JMW, Coulie PG, Geenen V, Vermeire S, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiologic considerations for drug use. Rheumatology. 2011;50:1955–68.PubMedPubMedCentralCrossRef Hazes JMW, Coulie PG, Geenen V, Vermeire S, et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiologic considerations for drug use. Rheumatology. 2011;50:1955–68.PubMedPubMedCentralCrossRef
go back to reference Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8:293–300.PubMedCrossRef Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8:293–300.PubMedCrossRef
go back to reference Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433–44.PubMedCrossRef Heneghan MA, Yeoman AD, Verma S, Smith AD, Longhi MS. Autoimmune hepatitis. Lancet. 2013;382:1433–44.PubMedCrossRef
go back to reference Hernández-Gea V, Baiges A, Turon F, et al. Idiopathic portal hypertension. Hepatology. 2018;68:2413–23.PubMedCrossRef Hernández-Gea V, Baiges A, Turon F, et al. Idiopathic portal hypertension. Hepatology. 2018;68:2413–23.PubMedCrossRef
go back to reference Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and noncirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol. 2019;71:175–99.PubMedCrossRef Hernández-Gea V, De Gottardi A, Leebeek FWG, Rautou PE, Salem R, Garcia-Pagan JC. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and noncirrhotic non-tumoral splanchnic vein thrombosis. J Hepatol. 2019;71:175–99.PubMedCrossRef
go back to reference Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11:364–70.PubMedCrossRef Hilfiker-Kleiner D, Sliwa K. Pathophysiology and epidemiology of peripartum cardiomyopathy. Nat Rev Cardiol. 2014;11:364–70.PubMedCrossRef
go back to reference Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38:2671–9.PubMedPubMedCentralCrossRef Hilfiker-Kleiner D, Haghikia A, Berliner D, et al. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J. 2017;38:2671–9.PubMedPubMedCentralCrossRef
go back to reference Hogeveen M, Blom HJ, Den Heijer M. Maternal homocysteine and small-for-gestational age offspring. Am J Clin Nutr. 2012;95:130–6. Hogeveen M, Blom HJ, Den Heijer M. Maternal homocysteine and small-for-gestational age offspring. Am J Clin Nutr. 2012;95:130–6.
go back to reference Holers VM, Girardi G, Mo L, Guthridge JM, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002;195:211–20.PubMedPubMedCentralCrossRef Holers VM, Girardi G, Mo L, Guthridge JM, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med. 2002;195:211–20.PubMedPubMedCentralCrossRef
go back to reference Horsley-Silva JL, Carey EJ, Lindor KD. Advances in primary sclerosing cholangitis. Lancet Gastroenterol Hepatol. 2016;1:68–77.PubMedCrossRef Horsley-Silva JL, Carey EJ, Lindor KD. Advances in primary sclerosing cholangitis. Lancet Gastroenterol Hepatol. 2016;1:68–77.PubMedCrossRef
go back to reference Huser M, Wagnerova K, Janku P, et al. Clinical mangement of pregnancy in women with Goodpasture syndrome. Gynecol Obstet Invest. 2015;79:73–7.PubMedCrossRef Huser M, Wagnerova K, Janku P, et al. Clinical mangement of pregnancy in women with Goodpasture syndrome. Gynecol Obstet Invest. 2015;79:73–7.PubMedCrossRef
go back to reference Imam MH, Gossard HH, Sinakos E, Lindor KD. Pathogenesis and management of pruritus in cholestatic liver disease. J Gastroenterol Hepatol. 2012;27:1150–8.PubMedCrossRef Imam MH, Gossard HH, Sinakos E, Lindor KD. Pathogenesis and management of pruritus in cholestatic liver disease. J Gastroenterol Hepatol. 2012;27:1150–8.PubMedCrossRef
go back to reference Ince-Ascan H, Dolhain RJEM. Pregnancy and rheumatoid arthritis. Best Pract & Res Clin Rheumatol. 2015;29:580–96.CrossRef Ince-Ascan H, Dolhain RJEM. Pregnancy and rheumatoid arthritis. Best Pract & Res Clin Rheumatol. 2015;29:580–96.CrossRef
go back to reference Islam A, Khandker SS, Alam F, Kamal MA, Gan SH. Genetic risk factors in thrombotic primary antiphospholipid syndrome: a systematic review with bioinformatic analyses. Autoimmun Rev. 2018;17:226–43.PubMedCrossRef Islam A, Khandker SS, Alam F, Kamal MA, Gan SH. Genetic risk factors in thrombotic primary antiphospholipid syndrome: a systematic review with bioinformatic analyses. Autoimmun Rev. 2018;17:226–43.PubMedCrossRef
go back to reference James AH. Review: thrombosis in pregnancy and maternal outcome. Birth Defect Res C Embryo Today. 2015;105:159–66.CrossRef James AH. Review: thrombosis in pregnancy and maternal outcome. Birth Defect Res C Embryo Today. 2015;105:159–66.CrossRef
go back to reference James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(suppl 5):54–9.PubMedCrossRef James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia. 2016;22(suppl 5):54–9.PubMedCrossRef
go back to reference Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjögren’s syndrome: novel aspects on pathogenesis. Immunol lett. 2011;141:1–9.PubMedCrossRef Jonsson R, Vogelsang P, Volchenkov R, et al. The complexity of Sjögren’s syndrome: novel aspects on pathogenesis. Immunol lett. 2011;141:1–9.PubMedCrossRef
go back to reference Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br. J Obstet Gynaecol. 1997;104:803–10.PubMedCrossRef Kadir RA, Economides DL, Braithwaite J, et al. The obstetric experience of carriers of haemophilia. Br. J Obstet Gynaecol. 1997;104:803–10.PubMedCrossRef
go back to reference Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.PubMedCrossRef Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.PubMedCrossRef
go back to reference Karlsen TH, Folseraas T, Thorburn T, Vesterhus M. Primary sclerosing cholangitis – a comprehensive review. J Hepatol. 2017;67:1298–323.PubMedCrossRef Karlsen TH, Folseraas T, Thorburn T, Vesterhus M. Primary sclerosing cholangitis – a comprehensive review. J Hepatol. 2017;67:1298–323.PubMedCrossRef
go back to reference Korevaar TIM et al. The consortium on Thyroid and Pregnancy, Study Group on Preterm Birth. JAMA 2019;322:632–641. Korevaar TIM et al. The consortium on Thyroid and Pregnancy, Study Group on Preterm Birth. JAMA 2019;322:632–641.
go back to reference Kuhn A, Wenzel J, Bijl M. Lupus erythematosus revisited. Semin Immunopathol. 2016;38:97–112 (Review). Kuhn A, Wenzel J, Bijl M. Lupus erythematosus revisited. Semin Immunopathol. 2016;38:97–112 (Review).
go back to reference Kusters DM, Lahsinoui HH, Van der Post JAM, et al. Statin use during pregnancy: a sytematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2012; PMID 22390808. Kusters DM, Lahsinoui HH, Van der Post JAM, et al. Statin use during pregnancy: a sytematic review and meta-analysis. Expert Rev Cardiovasc Ther. 2012; PMID 22390808.
go back to reference Lassi ZS, Salam RA, Haider BA, et al. Folic acid supplementation duirng pregnancy for maternal health and pregnancy outcomes (rev). Cochrane Database Syst Rev. 2013;3:CD006896. Lassi ZS, Salam RA, Haider BA, et al. Folic acid supplementation duirng pregnancy for maternal health and pregnancy outcomes (rev). Cochrane Database Syst Rev. 2013;3:CD006896.
go back to reference Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin N Am. 2017;43:215–26.CrossRef Lateef A, Petri M. Systemic lupus erythematosus and pregnancy. Rheum Dis Clin N Am. 2017;43:215–26.CrossRef
go back to reference Lau E, Defaria Yeh D. Management of high-risk cardiac conditions in pregnancy: anticoagulation, severe stenotic valvular disease and cardiomyopathy. Trends Cardiovasc Med. 2019;29:155–61.PubMedCrossRef Lau E, Defaria Yeh D. Management of high-risk cardiac conditions in pregnancy: anticoagulation, severe stenotic valvular disease and cardiomyopathy. Trends Cardiovasc Med. 2019;29:155–61.PubMedCrossRef
go back to reference Lemus HN, Warrington AE, Rodriguez M. Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin. 2019;36:11. Lemus HN, Warrington AE, Rodriguez M. Multiple sclerosis: mechanisms of disease and strategies for myelin and axonal repair. Neurol Clin. 2019;36:11.
go back to reference Li JM, Nguyen C, Joglar JA, et al. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetrical service. Clin Cardiol. 2008;31(11):538–41.PubMedPubMedCentralCrossRef Li JM, Nguyen C, Joglar JA, et al. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetrical service. Clin Cardiol. 2008;31(11):538–41.PubMedPubMedCentralCrossRef
go back to reference Li J, Sullivan JA, Ni H. Pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2018;25:373–81.PubMedCrossRef Li J, Sullivan JA, Ni H. Pathophysiology of immune thrombocytopenia. Curr Opin Hematol. 2018;25:373–81.PubMedCrossRef
go back to reference Liu Y, Ma X, Zheng J, Liu X, Yan T. A systematic review and meta-analysis of kidney and pregnancy outcome in IgA nephropathy. Am J Nephrol. 2016;44:187–93.PubMedCrossRef Liu Y, Ma X, Zheng J, Liu X, Yan T. A systematic review and meta-analysis of kidney and pregnancy outcome in IgA nephropathy. Am J Nephrol. 2016;44:187–93.PubMedCrossRef
go back to reference Liu J, Ghaziani TT, Wolf JL. Acute fatty liver of pregnancy: updates in pathogenesis. Diagnosis and Management. Am J Gastroenterol. 2017;112:838–46.PubMedCrossRef Liu J, Ghaziani TT, Wolf JL. Acute fatty liver of pregnancy: updates in pathogenesis. Diagnosis and Management. Am J Gastroenterol. 2017;112:838–46.PubMedCrossRef
go back to reference Llovet LP, Horta D, García Eliz M, Belenguer M, Fábrega E, et al. Pregnancy and autoimmune hepatitis: presentation and outcomes. Clin Gasteroenterol Hepatol. 2019, Jan 4 [Epub ahead of print]. Llovet LP, Horta D, García Eliz M, Belenguer M, Fábrega E, et al. Pregnancy and autoimmune hepatitis: presentation and outcomes. Clin Gasteroenterol Hepatol. 2019, Jan 4 [Epub ahead of print].
go back to reference Lopes van Balen VA, Spaan J, Ghossein C, et al. Early pregnancy circulatory adaptation and recurrent hypertensive disease. An explorative study. Reprod Sci. 2013;20:1069–74. Lopes van Balen VA, Spaan J, Ghossein C, et al. Early pregnancy circulatory adaptation and recurrent hypertensive disease. An explorative study. Reprod Sci. 2013;20:1069–74.
go back to reference Ludvigsson JF, Bergquist A, Ajne G, Kane S, et al. A Population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2014;12:95–100.PubMedCrossRef Ludvigsson JF, Bergquist A, Ajne G, Kane S, et al. A Population-based cohort study of pregnancy outcomes among women with primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2014;12:95–100.PubMedCrossRef
go back to reference Ma RCW, Tutino GE, Lillycrop KA, et al. Maternal diabetes, gestational diabetes and the role of epigenetics in their long-term effects on offspring. Progr Biophys Mol Biol. 2015;118:55–68. Ma RCW, Tutino GE, Lillycrop KA, et al. Maternal diabetes, gestational diabetes and the role of epigenetics in their long-term effects on offspring. Progr Biophys Mol Biol. 2015;118:55–68.
go back to reference Magee C, Grieve DJ, Watson CJ, Brazil DP. Diabetic nephropathy: a tangled web to unweave. Cardiovasc Drugs Ther. 2017;31:579–92. Magee C, Grieve DJ, Watson CJ, Brazil DP. Diabetic nephropathy: a tangled web to unweave. Cardiovasc Drugs Ther. 2017;31:579–92.
go back to reference Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM. Pregnancy outcomes following maternal kidney transplantation: a national cohort study. Acta Obstet Gynecol Scand. 2016;95:1153–61.PubMedCrossRef Majak GB, Sandven I, Lorentzen B, Vangen S, Reisaeter AV, Henriksen T, Michelsen TM. Pregnancy outcomes following maternal kidney transplantation: a national cohort study. Acta Obstet Gynecol Scand. 2016;95:1153–61.PubMedCrossRef
go back to reference Malik GH, Al-Harbi HS, Al-Mohaya, Al-Wakeel S, et al. Repeated pregnancies in patients with primary membranous glomerulonephritis. Nephron. 2002;91:21–4. Malik GH, Al-Harbi HS, Al-Mohaya, Al-Wakeel S, et al. Repeated pregnancies in patients with primary membranous glomerulonephritis. Nephron. 2002;91:21–4.
go back to reference Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis–Update 2015. J Hepatol. 2015;62(1 Suppl):S100–11.PubMedCrossRef Manns MP, Lohse AW, Vergani D. Autoimmune hepatitis–Update 2015. J Hepatol. 2015;62(1 Suppl):S100–11.PubMedCrossRef
go back to reference Marti-Carvajal AJ, Sola I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. The Cochrane Library. 2013; issue 1. Marti-Carvajal AJ, Sola I, Lathyris D, et al. Homocysteine-lowering interventions for preventing cardiovascular events. The Cochrane Library. 2013; issue 1.
go back to reference Mathiassen ON, Buus NH, Sihm I, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens. 2007;25:1021–6.PubMedCrossRef Mathiassen ON, Buus NH, Sihm I, et al. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens. 2007;25:1021–6.PubMedCrossRef
go back to reference McDonald-Wallis C, Lawlor DA, Fraser A, et al. Blood pressure change in normotensive, gestational hypertensive, preeclamptic and essential hypertensive pregnancies. Hypertension. 2012;59:1241–8.CrossRef McDonald-Wallis C, Lawlor DA, Fraser A, et al. Blood pressure change in normotensive, gestational hypertensive, preeclamptic and essential hypertensive pregnancies. Hypertension. 2012;59:1241–8.CrossRef
go back to reference Meng ML, Landau R, Viktorsdottir O, Banayan J, Grant T, Bateman B, Smiley R, Reitman E. Pulmonary hypertension in pregnancy. A report of 49 cases at four Tertiary North American Sites. Obstet Gynecol. 2017;129:511–20. Meng ML, Landau R, Viktorsdottir O, Banayan J, Grant T, Bateman B, Smiley R, Reitman E. Pulmonary hypertension in pregnancy. A report of 49 cases at four Tertiary North American Sites. Obstet Gynecol. 2017;129:511–20.
go back to reference Metz TD, Khanna A. Evaluation and management of maternal cardiac arrhythmias. Obstet Gynecol Clin N Am. 2016;43:729–45.CrossRef Metz TD, Khanna A. Evaluation and management of maternal cardiac arrhythmias. Obstet Gynecol Clin N Am. 2016;43:729–45.CrossRef
go back to reference Mignini LE, Latthe P, Villar J, et al. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol. 2005;105:411–25.PubMedCrossRef Mignini LE, Latthe P, Villar J, et al. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynecol. 2005;105:411–25.PubMedCrossRef
go back to reference Molodecky NA, Kareemi A, Parab R, Barkema HW, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590–9.PubMedCrossRef Molodecky NA, Kareemi A, Parab R, Barkema HW, et al. Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis. Hepatology. 2011;53:1590–9.PubMedCrossRef
go back to reference Moore JS, Teefey P, Rao K, et al. Maternal arrhythmia; a case report and review of the literature. Obstet Gynecol Survey. 2012;292–312. Moore JS, Teefey P, Rao K, et al. Maternal arrhythmia; a case report and review of the literature. Obstet Gynecol Survey. 2012;292–312.
go back to reference Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol. 2018;14:489–98.PubMedCrossRef Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol. 2018;14:489–98.PubMedCrossRef
go back to reference Morton A, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstet Med. 2018;11:126–31.PubMedPubMedCentralCrossRef Morton A, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstet Med. 2018;11:126–31.PubMedPubMedCentralCrossRef
go back to reference Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol. 2012;110:49–55.PubMedCrossRef Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol. 2012;110:49–55.PubMedCrossRef
go back to reference Naoum EE, Leffert LR, Chitilian HV, Gray KJ, Bateman BT. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications and obstetric management. Anesthesiology. 2019;130:446–61.PubMedCrossRef Naoum EE, Leffert LR, Chitilian HV, Gray KJ, Bateman BT. Acute fatty liver of pregnancy: pathophysiology, anesthetic implications and obstetric management. Anesthesiology. 2019;130:446–61.PubMedCrossRef
go back to reference Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. J Clin Invest. 1997;100:2680–90.PubMedPubMedCentralCrossRef Napoli C, D’Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. J Clin Invest. 1997;100:2680–90.PubMedPubMedCentralCrossRef
go back to reference Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Hotline editorial. Eur Heart J. 2001;22:4–9.CrossRef Napoli C, Palinski W. Maternal hypercholesterolemia during pregnancy influences the later development of atherosclerosis: clinical and pathogenic implications. Hotline editorial. Eur Heart J. 2001;22:4–9.CrossRef
go back to reference Neave L, Scully M. Microangiopathic hemolytic anemia and pregnancy. Transfus Med Rev. 2018;32:230–6.PubMedCrossRef Neave L, Scully M. Microangiopathic hemolytic anemia and pregnancy. Transfus Med Rev. 2018;32:230–6.PubMedCrossRef
go back to reference Negro R, Mestman JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25:927–43.PubMedCrossRef Negro R, Mestman JH. Thyroid disease in pregnancy. Best Pract Res Clin Endocrinol Metab. 2011;25:927–43.PubMedCrossRef
go back to reference Nishimura RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Thorac Cardiovasc Surg. 2014;148:e1–132. Nishimura RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Thorac Cardiovasc Surg. 2014;148:e1–132.
go back to reference Nishimura RA, et al. 2017 focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;70:259–89.CrossRef Nishimura RA, et al. 2017 focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;70:259–89.CrossRef
go back to reference Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378:169–81.PubMedCrossRef Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378:169–81.PubMedCrossRef
go back to reference Nurden P, Nurden AT. Congenital disorders associated with platelet disfunctions. Thromb Haemost. 2008;99:253–63.PubMedCrossRef Nurden P, Nurden AT. Congenital disorders associated with platelet disfunctions. Thromb Haemost. 2008;99:253–63.PubMedCrossRef
go back to reference O’Donnell JS, O’Sullivan JM, Preston RJS. Advances in understanding the molecular mechanisms that maintain normal haemostasis. Br J Haematol. 2019;186:214–36. O’Donnell JS, O’Sullivan JM, Preston RJS. Advances in understanding the molecular mechanisms that maintain normal haemostasis. Br J Haematol. 2019;186:214–36.
go back to reference O’Shaughnessy MM, Jobson MA, Sims K, Liberty AL, Nachman PH, Pendergraft WF. Pregnancy outcomes in patients with glomerular disease attending a single academic center in North Carolina. Am J Nephrol. 2017;45:442–51.PubMedCrossRef O’Shaughnessy MM, Jobson MA, Sims K, Liberty AL, Nachman PH, Pendergraft WF. Pregnancy outcomes in patients with glomerular disease attending a single academic center in North Carolina. Am J Nephrol. 2017;45:442–51.PubMedCrossRef
go back to reference Obican SG, Cleary KL. Pulmonary arterial hypertension in pregnancy. Seminar Perinatol. 2014;38:289–94.CrossRef Obican SG, Cleary KL. Pulmonary arterial hypertension in pregnancy. Seminar Perinatol. 2014;38:289–94.CrossRef
go back to reference Olsson KM, Channick R. Pregnancy in pulmonary hypertension. Eur J Respir Rev. 2016;25:431–7.CrossRef Olsson KM, Channick R. Pregnancy in pulmonary hypertension. Eur J Respir Rev. 2016;25:431–7.CrossRef
go back to reference Op de Beeck A, Elzirik DL. Viral infections in type 1 diabetes mellitus – why the β-cells? Nat Rev Endocrinol. 2016;12:263–73. Op de Beeck A, Elzirik DL. Viral infections in type 1 diabetes mellitus – why the β-cells? Nat Rev Endocrinol. 2016;12:263–73.
go back to reference Ope-Adenuga S, Moretti M, Lakhi N. Management of membranous glomerulonephritis in pregnancy: a multidisciplinary challenge. Case Rep Obstet Gynecol. 2015;2015:839376.PubMedPubMedCentral Ope-Adenuga S, Moretti M, Lakhi N. Management of membranous glomerulonephritis in pregnancy: a multidisciplinary challenge. Case Rep Obstet Gynecol. 2015;2015:839376.PubMedPubMedCentral
go back to reference Orwat S, Diller GP, Van Hagen JM, et al. Risk of pregnancy in moderate and severe aortic stenosis. J Am Coll Cardiol. 2016;68:1727–37.PubMedCrossRef Orwat S, Diller GP, Van Hagen JM, et al. Risk of pregnancy in moderate and severe aortic stenosis. J Am Coll Cardiol. 2016;68:1727–37.PubMedCrossRef
go back to reference Ovadia C, Williamson C. Intrahepatic cholestasis of pregnancy: recent advances. Clin Dermatol. 2016;34:327–34.PubMedCrossRef Ovadia C, Williamson C. Intrahepatic cholestasis of pregnancy: recent advances. Clin Dermatol. 2016;34:327–34.PubMedCrossRef
go back to reference Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes and cardiovascular risk. Curr Atheroscler Rep. 2014;16:419, 8 pages. Paneni F, Costantino S, Cosentino F. Insulin resistance, diabetes and cardiovascular risk. Curr Atheroscler Rep. 2014;16:419, 8 pages.
go back to reference Parikh P, Blauwet L. Peripartum cardiomyopathy and preeclampsia: overlapping diseases of pregnancy. Curr Hypertens Rep. 2018;20:69 (8 pages). Parikh P, Blauwet L. Peripartum cardiomyopathy and preeclampsia: overlapping diseases of pregnancy. Curr Hypertens Rep. 2018;20:69 (8 pages).
go back to reference Pearce EN. Thyroid disorders during pregnancy and postpartum. Best Pract Res Clin Obstet Gynaecol. 2015;29:700–6.PubMedCrossRef Pearce EN. Thyroid disorders during pregnancy and postpartum. Best Pract Res Clin Obstet Gynaecol. 2015;29:700–6.PubMedCrossRef
go back to reference Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature Rev Immunol. 2014;14:181–94.CrossRef Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nature Rev Immunol. 2014;14:181–94.CrossRef
go back to reference Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthitis Rheum. 2012;64:2677–86.CrossRef Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthitis Rheum. 2012;64:2677–86.CrossRef
go back to reference Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments and its complications. Lancet. 2016;388:187–97.PubMedCrossRef Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments and its complications. Lancet. 2016;388:187–97.PubMedCrossRef
go back to reference Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.PubMedCrossRef Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.PubMedCrossRef
go back to reference Puljic A, Salati J, Doss A, Caughey AB. Outcome of pregnancies complicated by liver cirrhosis, portal hypertension or esophageal varices. J Mat, Fetal, Neon Med. 2016;29:506–9.CrossRef Puljic A, Salati J, Doss A, Caughey AB. Outcome of pregnancies complicated by liver cirrhosis, portal hypertension or esophageal varices. J Mat, Fetal, Neon Med. 2016;29:506–9.CrossRef
go back to reference Rahman T, Hamzan NS, Mokhsin A et al. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study. Lipids Health Disease. 2017;16:81:PMID 28438163. Rahman T, Hamzan NS, Mokhsin A et al. Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study. Lipids Health Disease. 2017;16:81:PMID 28438163.
go back to reference Rautou PE, Angermayr B, Garcia-Pagan JC, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol. 2009;51:47–54.PubMedCrossRef Rautou PE, Angermayr B, Garcia-Pagan JC, et al. Pregnancy in women with known and treated Budd-Chiari syndrome: maternal and fetal outcomes. J Hepatol. 2009;51:47–54.PubMedCrossRef
go back to reference Reese JA, Peck JD, Deschamps DR, et al. Platelet count during pregnancy. New Engl J Med. 2018;379:32–43.PubMedCrossRef Reese JA, Peck JD, Deschamps DR, et al. Platelet count during pregnancy. New Engl J Med. 2018;379:32–43.PubMedCrossRef
go back to reference Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost. 2016;47:717–23.CrossRef Reynen E, James P. Von Willebrand disease and pregnancy: a review of evidence and expert opinion. Semin Thromb Hemost. 2016;47:717–23.CrossRef
go back to reference Rezk M, Masood A, Dawood R, et al. Improved pregnancy outcome following earlier splenectomy in women with immune thrombocytopenia: a 5 years observational study. J Matern Fetal Neonatal Med. 2018;31:2436–40.PubMedCrossRef Rezk M, Masood A, Dawood R, et al. Improved pregnancy outcome following earlier splenectomy in women with immune thrombocytopenia: a 5 years observational study. J Matern Fetal Neonatal Med. 2018;31:2436–40.PubMedCrossRef
go back to reference Riess FC, Gross A, Budde U. Pulmonary embolism after cesarian section due to heparin-induced thrombocytopenia despite normal platelet count. Thorac Cardiovasc Surg. 2005;53:255–7.PubMedCrossRef Riess FC, Gross A, Budde U. Pulmonary embolism after cesarian section due to heparin-induced thrombocytopenia despite normal platelet count. Thorac Cardiovasc Surg. 2005;53:255–7.PubMedCrossRef
go back to reference Roeder HA, Kuller JA, Barker PCA, et al. Maternal valvular heart disease in pregnancy. Obstet Gynecol Survey. 2011;66:561–71.CrossRef Roeder HA, Kuller JA, Barker PCA, et al. Maternal valvular heart disease in pregnancy. Obstet Gynecol Survey. 2011;66:561–71.CrossRef
go back to reference Ronco P, Debiec H. Membranous nephropathy: a fairy tale for immunopathologists, nephrologists and patients. Mol Immunol. 2015;68:57–62.PubMedCrossRef Ronco P, Debiec H. Membranous nephropathy: a fairy tale for immunopathologists, nephrologists and patients. Mol Immunol. 2015;68:57–62.PubMedCrossRef
go back to reference Rosenn B, Miodovnik M, Combs CA, Khoury J, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994;84:515–20.PubMed Rosenn B, Miodovnik M, Combs CA, Khoury J, et al. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol. 1994;84:515–20.PubMed
go back to reference Rossier BC, Bochud M, Devuyst O. The hypertensive pandemic: an evolutionary perspective. Physiology. 2017;32:112–25.PubMedCrossRef Rossier BC, Bochud M, Devuyst O. The hypertensive pandemic: an evolutionary perspective. Physiology. 2017;32:112–25.PubMedCrossRef
go back to reference Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid Syndrome (Seminar). Lancet. 2010;376:1498–509.CrossRefPubMed Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid Syndrome (Seminar). Lancet. 2010;376:1498–509.CrossRefPubMed
go back to reference Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Seminars Perinatol. 1998;22:156–65.CrossRef Russell MA, Craigo SD. Cirrhosis and portal hypertension in pregnancy. Seminars Perinatol. 1998;22:156–65.CrossRef
go back to reference Samuelson-Bannow BS, Konkle BA. Inherited bleeding disorders in the obstetric patient. Transfus Med Rev. 2018;32:237–43.CrossRef Samuelson-Bannow BS, Konkle BA. Inherited bleeding disorders in the obstetric patient. Transfus Med Rev. 2018;32:237–43.CrossRef
go back to reference Sanders DB, Wolfe GI, Narayanaswami P, et al. Developing treatment guidelines for myasthenia gravis. Ann NY Acad Sci. 2018;1412:95–101. Sanders DB, Wolfe GI, Narayanaswami P, et al. Developing treatment guidelines for myasthenia gravis. Ann NY Acad Sci. 2018;1412:95–101.
go back to reference Sanhal CY, Kara O, Yucel A. Can fetal left-ventricular modified myocardial performance index predict adverse perinatal outcomes in intrahepatic cholestasis of pregnancy? J Matern fetal Neonatal Med. 2017;30:911–6.PubMedCrossRef Sanhal CY, Kara O, Yucel A. Can fetal left-ventricular modified myocardial performance index predict adverse perinatal outcomes in intrahepatic cholestasis of pregnancy? J Matern fetal Neonatal Med. 2017;30:911–6.PubMedCrossRef
go back to reference Scaldaferri F, Pizzoferrato M, Ponziani FR, et al. Use and indications of cholestyramine and bile acid sequestrants. Intern Emerg Med. 2013;8:205–10.PubMedCrossRef Scaldaferri F, Pizzoferrato M, Ponziani FR, et al. Use and indications of cholestyramine and bile acid sequestrants. Intern Emerg Med. 2013;8:205–10.PubMedCrossRef
go back to reference Shi-Min Yuan, Song-Li Yan. Mitral valve prolapse in pregnancy. Braz J Cardiovasc Surg. 2016;31:158–62. Shi-Min Yuan, Song-Li Yan. Mitral valve prolapse in pregnancy. Braz J Cardiovasc Surg. 2016;31:158–62.
go back to reference Singh AG, Chowdhary VR. Pregnancy-related issues in women with systemic lupus erythematosus. Int J Rheum Dis. 2015;18:172–81.PubMedCrossRef Singh AG, Chowdhary VR. Pregnancy-related issues in women with systemic lupus erythematosus. Int J Rheum Dis. 2015;18:172–81.PubMedCrossRef
go back to reference Skeith L, Rydz N, O’Beirne M, et al. Pregnancy loss in women with von Willebrand disease: a single-center pilot study. Blood Coagul Fibrinolysis. 2017;28:393–7.PubMedCrossRef Skeith L, Rydz N, O’Beirne M, et al. Pregnancy loss in women with von Willebrand disease: a single-center pilot study. Blood Coagul Fibrinolysis. 2017;28:393–7.PubMedCrossRef
go back to reference Sliwa K, Johnson MR, Zilla P, et al. Management of valvular heart disease in pregnancy: a global perspective. Eur Heart J. 2015;36:1078–89.PubMedCrossRef Sliwa K, Johnson MR, Zilla P, et al. Management of valvular heart disease in pregnancy: a global perspective. Eur Heart J. 2015;36:1078–89.PubMedCrossRef
go back to reference Smeele HTW, Dolhain RJEM. Current perspectives on fertility, pregnancy and childbirth in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2019;49:S32–5.PubMedCrossRef Smeele HTW, Dolhain RJEM. Current perspectives on fertility, pregnancy and childbirth in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2019;49:S32–5.PubMedCrossRef
go back to reference Smolen JS, Aletaha D, McInnes IB, Rheumatoid arthritis. (Seminar) Lancet. 2016;388:2023–38. Smolen JS, Aletaha D, McInnes IB, Rheumatoid arthritis. (Seminar) Lancet. 2016;388:2023–38.
go back to reference Smulders YM. The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia. Neth J Med. 2000;57:172–3.PubMedCrossRef Smulders YM. The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia. Neth J Med. 2000;57:172–3.PubMedCrossRef
go back to reference Spaanderman M, Ekhart T, Van Eyk J et al. Preeclampsia and maladaptation to pregnancy. A role for atrial natriuretic peptide? Kidney Int. 2001;60:1397–406. Spaanderman M, Ekhart T, Van Eyk J et al. Preeclampsia and maladaptation to pregnancy. A role for atrial natriuretic peptide? Kidney Int. 2001;60:1397–406.
go back to reference Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475–80.PubMedCrossRef Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475–80.PubMedCrossRef
go back to reference Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol. 2012;8:439–53.PubMedCrossRef Stojan G, Baer AN. Flares of systemic lupus erythematosus during pregnancy and the puerperium: prevention, diagnosis and management. Expert Rev Clin Immunol. 2012;8:439–53.PubMedCrossRef
go back to reference Tangren J, Nadel M, Hladunewich MA. Pregnancy and end-stage renal disease. Blood Purf. 2018;45:194–200.CrossRef Tangren J, Nadel M, Hladunewich MA. Pregnancy and end-stage renal disease. Blood Purf. 2018;45:194–200.CrossRef
go back to reference Tao Z, Shi A, Zhao J. Epidemiological perspectives of diabetes. Cell Biochem Biophys. 2015;73:181–5.PubMedCrossRef Tao Z, Shi A, Zhao J. Epidemiological perspectives of diabetes. Cell Biochem Biophys. 2015;73:181–5.PubMedCrossRef
go back to reference Theocharidou E, Heneghan MA. Current and future perspectives in autoimmune hepatitis. Brit J Hosp Med. 2018;79:151–9.CrossRef Theocharidou E, Heneghan MA. Current and future perspectives in autoimmune hepatitis. Brit J Hosp Med. 2018;79:151–9.CrossRef
go back to reference Thomas E, Yang J, Jianjin X, Lima FV, Stergiopoulos K. Pulmonary hypertension and pregnancy outcomes: insights of the national inpatient sample. J Am Heart Assoc. 2017;6:1–12.CrossRef Thomas E, Yang J, Jianjin X, Lima FV, Stergiopoulos K. Pulmonary hypertension and pregnancy outcomes: insights of the national inpatient sample. J Am Heart Assoc. 2017;6:1–12.CrossRef
go back to reference Thöne J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy – safety considerations. Expert Opin Drug Saf. 2017;16:523–34.PubMedCrossRef Thöne J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy – safety considerations. Expert Opin Drug Saf. 2017;16:523–34.PubMedCrossRef
go back to reference Tiniakos DG. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Eur J Gastroenterol Hepatol. 2010;22:643–50.PubMed Tiniakos DG. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems. Eur J Gastroenterol Hepatol. 2010;22:643–50.PubMed
go back to reference Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111:176–94.PubMedCrossRef Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111:176–94.PubMedCrossRef
go back to reference Tsiara S, Poppas A. Mitral valve disease in pregnancy: outcomes and management. Obstet Med. 2009;2:6–10. Tsiara S, Poppas A. Mitral valve disease in pregnancy: outcomes and management. Obstet Med. 2009;2:6–10.
go back to reference Valera MC, Parant O, Vayssiere C, et al. Essential thrombocythemia and pregnancy. Eur J Obstet gynecol Reprod Biol. 2011;158:141–7.PubMedCrossRef Valera MC, Parant O, Vayssiere C, et al. Essential thrombocythemia and pregnancy. Eur J Obstet gynecol Reprod Biol. 2011;158:141–7.PubMedCrossRef
go back to reference Van de Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and on early pregnancy: a systematic review. Human Reprod Update. 2011;17:605–19. (minor corrections on this report with no impact on outcome, were published in Human Reprod Update. 2016;22:532–3). Van de Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and on early pregnancy: a systematic review. Human Reprod Update. 2011;17:605–19. (minor corrections on this report with no impact on outcome, were published in Human Reprod Update. 2016;22:532–3).
go back to reference Van de Griend R, Biesma DH, Banga JD. Hyperhomocysteinaemia as a cardiovascular risk factor; an update. Neth J Med. 2000;56:119–30.PubMedCrossRef Van de Griend R, Biesma DH, Banga JD. Hyperhomocysteinaemia as a cardiovascular risk factor; an update. Neth J Med. 2000;56:119–30.PubMedCrossRef
go back to reference Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik G, Williamson C. Heart and bile acids – Clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1345–55.PubMedCrossRef Vasavan T, Ferraro E, Ibrahim E, Dixon P, Gorelik G, Williamson C. Heart and bile acids – Clinical consequences of altered bile acid metabolism. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1345–55.PubMedCrossRef
go back to reference Vilas-Boas A, Bakshi J, Isenberg DA. What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy? Expert Rev Clin Immunol. 2015;11:1093–107.PubMedCrossRef Vilas-Boas A, Bakshi J, Isenberg DA. What can we learn from systemic lupus erythematosus pathophysiology to improve current therapy? Expert Rev Clin Immunol. 2015;11:1093–107.PubMedCrossRef
go back to reference Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.PubMedCrossRef Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.PubMedCrossRef
go back to reference Wellge BE, Sterneck E, Teufel A, Rust C, Franke A, Schreiber S, et al. Pregnancy in primary sclerosing cholangitis. Gut. 2011;60:1117–21.PubMedCrossRef Wellge BE, Sterneck E, Teufel A, Rust C, Franke A, Schreiber S, et al. Pregnancy in primary sclerosing cholangitis. Gut. 2011;60:1117–21.PubMedCrossRef
go back to reference Wender-Ozegowska E, Wroblewska K, Zawiejska A, et al. Threshold values of maternal blood glucose in early diabetic pregnancy – prediction of fetal malformations. Acta Obstet Gynecol Scand. 2005;84:17–25. Wender-Ozegowska E, Wroblewska K, Zawiejska A, et al. Threshold values of maternal blood glucose in early diabetic pregnancy – prediction of fetal malformations. Acta Obstet Gynecol Scand. 2005;84:17–25.
go back to reference Wikström-Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson S, Marschall H-U. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol. 2015;63:456–61.PubMedCrossRef Wikström-Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson S, Marschall H-U. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: a population-based cohort study. J Hepatol. 2015;63:456–61.PubMedCrossRef
go back to reference Wolberg AS, Aleman MM, Leiderman K, et al. Procoagulant activity in hemostasis and thrombosis: Virchow’s triad revisited. Anesth Analg. 2012;114:275–85.PubMedCrossRef Wolberg AS, Aleman MM, Leiderman K, et al. Procoagulant activity in hemostasis and thrombosis: Virchow’s triad revisited. Anesth Analg. 2012;114:275–85.PubMedCrossRef
go back to reference Wu M-Y, Chen C-S, Yiang G-T, Cheng P-W, et al. The emerging role of pathogenesis of IgA nephropathy. J Clin Med. 2018 Aug 20;7:pii:E225 (16 pages). Wu M-Y, Chen C-S, Yiang G-T, Cheng P-W, et al. The emerging role of pathogenesis of IgA nephropathy. J Clin Med. 2018 Aug 20;7:pii:E225 (16 pages).
go back to reference Xiong H-F, Liu J-Y, Guo L-M, Li X-W. Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients. World J Gastroenterol. 2015;21:1927–31.PubMedPubMedCentralCrossRef Xiong H-F, Liu J-Y, Guo L-M, Li X-W. Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients. World J Gastroenterol. 2015;21:1927–31.PubMedPubMedCentralCrossRef
go back to reference Yanagawa B, Whitlock RP, Verma S, et al. Anticoagulation for prosthetic heart valves: unresolved questions requiring answers. Curr Opin Cardiol. 2016;31:176–82.PubMedCrossRef Yanagawa B, Whitlock RP, Verma S, et al. Anticoagulation for prosthetic heart valves: unresolved questions requiring answers. Curr Opin Cardiol. 2016;31:176–82.PubMedCrossRef
go back to reference Yancy CW, et al. ACCF/AHA guideline for the management of heart failure. Circulation. 2013;128:e240–327. (updated in 2017). Yancy CW, et al. ACCF/AHA guideline for the management of heart failure. Circulation. 2013;128:e240–327. (updated in 2017).
go back to reference Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver international. 2018;38:399–411.PubMedCrossRef Zakharia K, Tabibian A, Lindor KD, Tabibian JH. Complications, symptoms, quality of life and pregnancy in cholestatic liver disease. Liver international. 2018;38:399–411.PubMedCrossRef
go back to reference Zamanpoor M. The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis. Clin Genet. 2019;95:547–57.PubMedCrossRef Zamanpoor M. The genetic pathogenesis, diagnosis and therapeutic insight of rheumatoid arthritis. Clin Genet. 2019;95:547–57.PubMedCrossRef
Metagegevens
Titel
Preexistent chronic disorders, often directly affecting pregnancy
Auteurs
Dr. L. L. H. Peeters
Prof. Dr. P. W. de Leeuw
Dr. E. D. Post Uiterweer
Copyright
2021
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2571-9_3